The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPARγ and SIRT-1 expression on a calorie restricted diet by Rahman, Md Mizanur et al.
www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  307
Oxidative Medicine and Cellular Longevity 2:5, 307-316; November/December 2009; © 2009 Landes Bioscience
 ReseaRCh papeR ReseaRCh papeR
Introduction
Oxidative stress is caused by an imbalance between the pro-
ductions of reactive oxygen species (ROS) and ROS neutraliz-
ing anti-oxidant enzymes. All forms of life maintain a reducing 
environment within their cells. This reducing environment is 
preserved by enzymes that maintain the reduced state through 
a constant input of metabolic energy. Disturbances in this nor-
mal redox state can cause toxic effects through the production 
of peroxides and free radicals that damage all components of the 
cell, including proteins, lipids and DNA. Inflammation is the 
body’s immediate response to initiate a repair mechanism when 
subjected to a foreign challenge (e.g., pathogens and toxins) or 
tissue injury. A normal inflammatory response is self-limiting 
and involves downregulation of pro-inflammatory mediators, 
and an increase in anti-inflammatory mediators. However, an 
over inflammatory response contributes to the pathogenesis of 
several  inflammatory  diseases.1  Inflammation  and  oxidative 
stress are associated with aging, as well as a vast majority of 
diseases, including cancer, cardiovascular diseases, hyperten-
sion, atherosclerosis, diabetes, osteoporosis, arthritis, sarcope-
nia, parkinson’s disease, Alzheimer’s disease and chronic fatigue 
syndrome. Therefore, strategies that can modulate both inflam-
mation and oxidative stress will ensure a reduction of pathologi-
cal conditions thereby promoting healthy aging and extension 
of life span.
n-3 fatty acids (FA), along with n-6 FA, are essential polyun-
saturated FA for optimal health. The western diet is abundant 
in n-6 FA, mainly from vegetable oils rich in linoleic acid and 
arachidonic acid (AA). The n-6 FA, especially AA, is a precursor 
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sirtuins have a significant potential to impact metabolic pathways 
involving glucose homeostasis, the insulin/IGF-1 signaling path-
way, and stress response pathways associated with DNA dam-
age and oxidative stress.21 Pointing to a possible role of sirtuins 
in mammalian aging and metabolism, two independent studies 
have demonstrated recently that oral administration of resvera-
trol (a natural compound enriched in grapes and identified as 
a direct activator of sirtuins) can reverse the pathophysiologic 
effects of high fat diet and restore life span.22,23 The PPARγ is a 
regulator of anti-inflammatory genes.24 Very recently, upregula-
tion of PPARγ has been shown to be associated with reduction of 
oxidative stress.24-27
In  2004,  Kang  et  al.  generated  transgenic  Fat-1  mouse 
(Fat-1)  on  C57BL6  background  carrying  the  fat-1  gene  from 
Caenorhabditis  elegans,  which  encodes  for  an  n-3  desaturase 
enzyme that can synthesize n-3 FA from n-6 FA.15,28 Different 
tissues of Fat-1 mice show increase in n-3 FA and decrease in n-6 
FA leading to a significant decrease in n-6/n-3 FA ratio. Thus, 
Fat-1 transgenic mice have an n-6/n-3 FA ratio of ~1:1 compared 
to wild-type mice with ratio of 20-30:1. Thus, the Fat-1 mouse 
represents a significant advance in the development of a more 
sophisticated research model to investigate the effect of n-3 FA 
and n-6/n-3 FA ratio on physiological parameters and molecular 
mechanisms without providing exogenous n-3 FA in the form 
of fish oil (FO). Recent studies with Fat-1 mouse have already 
yielded interesting results including reduction of inflammation, 
bone loss, lung injury, colitis, colon cancer, melanoma growth, 
invasiveness of lung cancer cells, and seizure susceptibility in 
Fat-1 transgenic mice.2,29-34 We and others have shown that Fat-1 
mice attenuate the inflammatory response following a bacterial 
lipopolysaccharide (LPS) challenge.29 In this study, we used Fat-1 
mice to examine if there is any synergistic effect of endogenously 
synthesized n-3 FA and 40% CR on the anti-inflammatory and 
anti-oxidative capacity in mice. Fat-1 mice exhibited a higher n-3 
FA and lower n-6/n-3 FA ratio in different tissues. There was 
a synergistic effect of endogenous n-3 FA and CR on lowering 
the production of pro-inflammatory cytokines and on enhanc-
ing the production of anti-oxidant enzymes, as well as enhancing 
the expression of PPARγ and the life prolonging gene SIRT-1, 
thereby may delay the progression of aging-associated pathologi-
cal consequences.
Results
Effect of fat-1 transgene and CR on fatty acid composition of 
serum, muscle and liver. The fat-1 gene of C. elegans encodes an 
n-3 fatty-acid desaturase enzyme that converts n-6 FA to n-3 FA 
and which is absent in most animals, including mammals.4 Both 
WT and Fat-1-transgenic littermates born to the same mother 
were maintained on an identical diet that was high in n-6 FA, but 
deficient in n-3 FA. However, the fatty-acid profiles of the two 
groups turned out to be quite different in different tissues ana-
lyzed by GC. In this study, we performed GC to determine the 
effect of fat-1 transgene on fatty acid composition of serum, mus-
cle and liver. Our results showed a decrease in n-6/n-3 FA ratio 
((18:2n-6 + 20:4n-6 +22:4n-6 + 22:5n-6)/(18:2n-6 + 20:4n-6 
of prostaglandins, leukotrienes and related compounds that influ-
ence the synthesis of eicosanoids, which may enhance inflamma-
tion.2 Anti-oxidative and anti-inflammatory properties of n-3 FA 
are well established. The consumption of fish, rich in n-3 FA, 
is recommended for its health benefits to protect against heart 
disease, diabetes and potentially cancer.3 Consuming increased 
amounts of long chain n-3 FA results in a partial replacement of 
the AA in cell membranes by eicosapentanoic acid (EPA 20:5) 
and docosahexanoic acid (DHA 22:6).4 This leads to a decreased 
production  of  AA-derived  mediators.  We  and  others  earlier 
reported the inhibition of pro-inflammatory cytokines produc-
tion by n-3 FA in cells and tissues.2,5-7 NFκB is the key regula-
tor of inflammatory pathways. We and others have reported that 
n-3 FA suppress the activation of NFκB in cells and tissues.2,6 It 
has been also reported that n-3 FA inhibit oxidative stress.8 It is 
widely accepted that fish oil (FO), rich in n-3 poly unsaturated 
fatty acids (PUFA), protect against several types of cardiovas-
cular diseases, such as myocardial infarction, arrhythmia, ath-
erosclerosis and hypertension.9 A recent health study in nurses 
revealed that a higher consumption of n-3 FA was associated with 
a lower risk of heart disease (HD), and particularly HD related 
deaths.10 Furthermore, the blood level of n-3 FA is considered 
as a predictive biomarker for sudden death in men.11 n-3 FA has 
also been reported to decrease plasma triglycerides, and increase 
serum HDL-cholesterol,12 which is associated with more efficient 
reverse cholesterol transport and a reduced risk of coronary heart 
disease.13 Our own studies, either with CR or n-3 FA, or recently 
with their combination, have shown several beneficial effects on 
antioxidant enzyme levels in BW and MRL/lpr mice.14
CR is considered as the only established anti-aging experi-
mental paradigm. CR’s anti-aging effects are thought to be due 
mainly to its powerful anti-inflammatory, resistance against oxi-
dative stress and its ability to maintain a proper cellular redox sta-
tus as evidenced by suppressed oxidative damage to lipids, DNA 
and proteins.15 The antioxidant defense system decreases with age 
and CR is shown to prevent these decreases.16 Thus, the effects 
of short- and long-term CR are believed to be due to its power-
ful anti-oxidative action.15 Recent evidence has also documented 
CR’s anti-inflammatory action, as shown in its modulation of 
pro-inflammatory genes such as TNFa, IL-1, IL-6, c reactive 
protein (CRP), adhesion molecules (AMs), iNOS and COX-2 
through the NFκB signaling pathway.15 Furthermore, it has been 
demonstrated the capacity of long-term 40% CR to attenuate the 
increase in circulating levels of CRP and reduced IL-6 secretion 
from adipose tissue.15 Animal studies have shown repeatedly that 
CR enhances metabolic efficiency, decreases inflammation and 
increases stress resistances over the lifespan, thereby delaying the 
onset of age-related pathological conditions.
The lifespan extension in yeast has been shown to be associ-
ated with increased activity of the Nicotinamide adenine dinucle-
otide (NAD)+-dependent protein deacetylase Sir2.17,18 Mammals 
express at least seven Sir2 orthologs, designated sirtuins (Sirt1-7), 
varying in cellular expression and function.19 Mammalian sir-
tuins have been shown to deacetylate and regulate a large array of 
substrates including p53, FOXO, tubulin and metabolic proteins 
such  as  PGC-1a,  PPARγ  and  acetyl-CoA  synthetase.20  Thus, www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  309
n-3 FA and CR on CAT and SOD activity in the liver. Similar to 
that of muscle, a slight increase in the activity of CAT and SOD 
was seen in both endogenously produced n-3 and CR mice liver 
(Fig. 4). However, the CAT and SOD activities were augmented 
in the liver of Fat-1/CR mice, as compared to that of WT/CR 
mice (Fig. 4). The results indicate a synergistic effect of n-3 FA 
and CR on augmenting the activity of anti-oxidant enzymes.
Effect of endogenous n-3 FA and CR on the SIRT-1 expres-
sion in liver. The anti-aging effects of human homologues of 
sirtuins, SIRT1-7, have been suggested by animal and human 
association  studies.37  It  has  been  also  reported  that  CR  pro-
motes mammalian cell survival by inducing SIRT1.38 However, 
the effect of n-3 FA or combined effect of n-3 FA and CR were 
+ 22:4n-6 + 22:5n-6)) in Fat-1/AL and Fat-1/CR mice, as com-
pared to WT/AL and WT/CR mice (Fig. 1). However, CR did 
not make any change in the fatty acid composition of tissues 
(Fig. 1). During this dietary regime, Fat-1 mice had significantly 
higher amounts of n-3 FA, such as eicosapentaenoic acid (EPA) 
(20:5 FA), docosapentaenoic acid (DPA) (22:5 FA) and doco-
sahexaenoic acid (DHA) (22:6 FA), in serum, muscle and liver 
as compared to that of WT mice (Data not shown). However, 
the reduction of n-6 FA in Fat-1 mice was not as dramatic as of 
increase in n-3 FA. There was no difference found in linoleic acid 
(LA) (18:2 n-6 FA) level in different tissues between the groups 
(Data not shown). Reduced level of arachidonic acid (AA) (20:4 
FA), 22:4 FA and 22:5 FA were found in different tissues of Fat-1 
mice as compared to that of WT mice (Data not shown). This 
indicates that the transgene is functionally active in vivo and is 
transmittable. The relative ratio between n-6 and n-3 FA is an 
important determinant in the overall health benefits of consum-
ing n-3 FA.35 The n-6 to n-3 FA ratio consumed in the present 
western diet is between 10:1 and 20:1; however, our ancestors 
had a diet closer to 1:1.36 A lower n-6 to n-3 FA ratio may be 
optimal for one’s health. Our findings suggest that a decrease in 
n-6/n-3 FA ratio in Fat-1 mice on AL and CR diets may contrib-
ute to the reduction of inflammation and oxidative stress.
Effect of endogenous n-3 FA and CR on serum pro-inflam-
matory cytokines levels. Both n-3 FA and CR are known to be 
anti-inflammatory. We determined the serum TNFa, IL-6 and 
IL-1b using standard ELISA techniques. We found both endoge-
nous n-3 FA and CR had the capacity to reduce the serum TNFa, 
IL-6 and IL-1b levels (Fig. 2). However, enhanced reduction of 
serum TNFa, IL-6 and IL-1b was observed in Fat-1/CR group, 
as compared to that of WT/CR group, WT/AL and Fat-1/AL 
groups (Fig. 2). These results suggest that endogenous n-3 FA 
and CR may have a synergistic effect on lowering the produc-
tion of pro-inflammatory cytokines in animals. Further, reduced 
levels of pro-inflammatory cytokines levels indicate that Fat-1 
mice on CR diet may exert less inflammatory response, which 
may improve pathological conditions during the progression of 
aging.
Effect  of  endogenous  n-3  FA  and  CR  on  anti-oxidant 
enzymes activity in muscle. Oxidative stress plays a major role 
in the progression of aging and diseases and the level of oxida-
tive stress depends on the balance between ROS and antioxidant 
enzymes activity. In this study, we have analyzed endogenous n-3 
FA and CR on the CAT, SOD and GPX activity in muscles. n-3 
FA and CR both enhanced the activity of CAT, SOD and GPX 
in muscles (Fig. 3). However, the activity of CAT, SOD and GPX 
was further augmented in muscles of Fat-1/CR mice, as compared 
to that of WT/CR, WT/AL and Fat-1/AL mice (Fig. 3). These 
results indicate that n-3 FA and CR may have a synergistic effect 
on augmenting the activity of anti-oxidant enzymes, which will 
neutralize the free radicals generated during the course of life and 
reduce the oxidative damage to DNA, lipids and proteins, thereby 
improving the pathological conditions during the progression of 
aging.
Effect of endogenous n-3 FA and CR on anti-oxidant enzymes 
activity in liver. We have also analyzed the effect of endogenous 
Figure 1. Polyunsaturated fatty acids (FA) profile of serum, liver and 
muscle from wild type (WT) and Fat-1 transgenic (Fat-1) mice fed aIN-
93M diet supplemented with 10% corn oil either on ad libitum (aL) or 
calorie restriction (CR) diet. Results are expressed as ratio of n-6 Fa: n-3 
Fa. Ratio of n-6/n-3 Fa is expressed as (18:2n-6 + 20:4n-6 + 22:4n-6 + 
22:5n-6)/(18:3n-3 + 20:5n-3 + 22:5n-3 + 22:6n-3). each bar represents 
the mean ± seM (n = 8–10/group). Value with different superscripts are 
significantly different at p < 0.05 by Newman-Keuls’ one way ANOVA with 
multiple comparison test. WT/aL, wild type ad libitum; WT/CR, wild type 
calorie restriction; Fat-1/aL, Fat-1 transgenic ad libitum; Fat-1/CR, Fat-1 
transgenic calorie restriction.310  Oxidative Medicine and Cellular Longevity  Volume 2 Issue 5
6). A slight but non-significant increase, in PPARγ expression 
was noted in the liver of Fat-1/CR mice, as compared to that of 
Fat-1/AL mice. However, a significantly higher level of PPARγ 
was observed in the liver of Fat-1/CR mice, as compared to that 
of WT/CR mice (Fig. 6).
To determine the synergistic effect of endogenously synthe-
sized n-3 fatty acids and CR, we have analyzed the data for dif-
ferent parameters by Two Way Anova using Graph Pad Prism 
software. We found synergistic effect of endogenously synthe-
sized n-3 fatty acids and CR on the expression of muscle catalase, 
liver PPARγ and liver SIRT-1 (Table 1). We also found interac-
tive effect although  not significant, on some other parameters 
(Table 1).
Discussion
The study presented here was designed to examine the effect of 
an endogenously increased n-3 PUFA status on the anti-inflam-
matory and anti-oxidative property of Fat-1 transgenic mice on 
a moderate CR diet. Significant reduction of pro-inflammatory 
cytokines production and augmentation of anti-oxidant enzymes 
production, along with enhanced expression of PPARγ and SIRT-
1, were observed in Fat-1/CR mice. These findings suggest that 
endogenous n-3 FA and CR, in combination, may prevent or 
delay the progression of inflammation and oxidative stress related 
pathological  consequences,  thereby  may  prolong  life  span.  In 
this study, we used Fat-1 transgenic mice, which were developed 
recently by Dr. Kang. These transgenic mice express a C. elegans 
desaturase, leading to the formation of high levels of n-3 PUFA 
endogenously from n-6 PUFA.28 In this study, mice were fed a 
n-6 enriched and n-3 FA deficient diet which resembles west-
ern diet which contains a n-6 to n-3 FA ratio of 10:1-20:1.36 
Different tissues of Fat-1 mice show an increase in n-3 FA, lead-
ing to a significant decrease in n-6/n-3 FA ratio, compared to 
WT mice. In our present study, we also found increased n-3 
FA and decreased n-6/n-3 FA ratio in serum, muscle and liver. 
Studies with Fat-1 mouse have already yielded interesting results 
and became a very valuable tool to study the effect of n-3 FA in 
health and diseases.2,29-34 Compared to a FA feeding study, using 
Fat-1 transgenic mice require only one diet to be provided to all 
experimental mice groups, thereby free of potential confound-
ers, like variations in calories with respect to fat content, sources 
or quality of different oils. Thus, the Fat-1 mouse represents a 
significant advance in the development of a more sophisticated 
research model to investigate the effect of n-3 FA and n-6/n-3 FA 
ratio on physiological parameters, inflammation, oxidative stress 
and molecular mechanisms, without providing exogenous n-3 FA 
in the form of fish oil (FO).
Inflammation is associated with aging and with various dis-
eases. Anti-inflammatory properties of both n-3 FA and CR are 
established. Earlier, we have showed that n-3 FA prevents ova-
riectomy induced osteoporosis, age-associated osteoporosis and 
arthritis  in  animal  models  by  attenuating  the  production  of 
pro-inflammatory cytokines and inflammatory osteotropic fac-
tors.6,34,40,41 Others have also showed that n-3 FA decrease proin-
flammatory cytokines production in tissues and cells.42 Recent 
not known. As reported by others, we also found an increase in 
SIRT-1 expression, due to CR in mice (Fig. 5). However, dra-
matic increase in SIRT-1 expression was noted in Fat-1/CR mice, 
as compare to that of WT/CR mice. These results support the 
notion that CR extends life span. These data also indicate that 
CR, along with n-3 FA supplementation, may extend the life span 
even further.
Effect of endogenous n-3 FA and CR on the PPARγ expres-
sion in liver. PPARγ is the key regulator of glucose, insulin and 
lipid metabolism. PPARγ agonists are underway to treat diabe-
tes, inflammation and cancer.39 In this study we have analyzed 
the effect of endogenous n-3 FA and CR on the expression of 
PPARγ in the liver. No effect of CR on the expression of PPARγ 
was found. However, a significant increase in PPARγ expression 
was noted, due to the endogenous production of n-3 FA (Fig. 
Figure 2. endogenous n-3 Fa and CR reduce serum tumor necrosis fac-
tor (TNF)a, interleukin (IL)-6 and IL-1b levels:  after 5 months of dietary 
intervention, blood was collected and serum was prepared. TNFa, IL-6 and 
IL-1b levels in serum were analyzed using TNFa, IL-6 and IL-1b eLIsa as-
say kits. Each bar represents the mean ± SEM (n = 8-10/group). Value with 
different superscripts are significantly different at p < 0.05 by Newman-
Keuls’ one way ANOVA. WT/AL, wild type ad libitum; WT/CR, wild type 
calorie restriction; Fat-1/aL, Fat-1 transgenic ad libitum; Fat-1/CR, Fat-1 
transgenic calorie restriction.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  311
evidence has also documented CR’s anti-inflammatory action, 
as shown in its modulation of pro-inflammatory genes, such as 
TNFa, IL-1, IL-6, c-reactive protein (CRP), adhesion molecules 
(AMs), iNOS and COX-2, through the NFκB signaling path-
way.15,43 In our previous study using Fat-1 mice fed 40% CR diet, 
we showed a synergistic effect of endogenous n-3 FA and CR on 
reducing pro-inflammatory cytokines production in LPS treated 
splenocytes. We showed that endogenous n-3 FA, in combination 
with CR, strongly inhibited the activation of two major intracel-
lular inflammatory signaling pathways, NFκB and AP-1. Earlier, 
we and others have also reported that n-3 FA inhibit NFκB activa-
tion.6,29,34,42 A synergistic anti-inflammatory effect of CR and n-3 
FA has been recently reported by others.15 In the present study, 
we found decreased serum IL-6, TNFa and IL-1b levels in Fat-1/
Figure 3. endogenous n-3 Fa and CR enhance muscle anti-oxidant 
enzymes activity: after 5 months of dietary intervention, muscle homo-
genates were prepared and used to determine the activity of catalase 
(CaT), superoxide dismutase (sOD) and glutathione peroxidase (GpX) as 
described in materials and methods section. each bar represents the mean 
± SEM (n = 8-10/group). Value with different superscripts are significantly 
different at p < 0.05 by Newman-Keuls’ one way ANOVA. WT/AL, wild 
type ad libitum; WT/CR, wild type calorie restriction; Fat-1/aL, Fat-1 trans-
genic ad libitum; Fat-1/CR, Fat-1 transgenic calorie restriction.
Figure 4. endogenous n-3 Fa and CR enhance liver anti-oxidant enzymes 
activity: after 5 months of dietary intervention, muscle homogenates were 
prepared and used to determine the activity of catalase (CaT), and super-
oxide dismutase (sOD) as described in materials and methods section. 
each bar represents the mean ± seM (n = 8-10/group). The p values shown 
on sOD bars were determined by students t test. WT/aL, wild type ad 
libitum; WT/CR, wild type calorie restriction; Fat-1/aL, Fat-1 transgenic ad 
libitum; Fat-1/CR, Fat-1 transgenic calorie restriction.
AL mice, compared to WT/AL mice. A further stronger reduc-
tion of serum pro-inflammatory cytokines levels was observed in 
Fat-1/CR mice, as compared to that of WT/CR mice. This is in 
concurrence with our previous Fat-1/CR study, as well as other 
studies, with n-3 FA feeding.29,42 It has also been reported that 
n-3 FA inhibited LPS-stimulated cytokine production in human 
mononuclear cells and THP-1 macrophages.44 CR was reported 
to prevent age-related increase in circulating TNFa and IL-6 in 
long-lived C3B10RF1 mice,45 in myocardial ischemia-reperfusion 
induced inflammation and other diseases.46 In the present study, 
CR alone exhibited a reduction of serum IL-1b level, without sig-
nificant reduction of serum IL-6 and TNFa levels. As seen in our 
previous Fat-1/CR study, a dramatic inhibition of serum TNFa, 
IL-6 and IL-1b was observed in Fat-1/CR mice, as compared to 
that of WT/CR mice. These data provide further evidence that 
n-3 FA and CR may have a synergistic anti-inflammatory effect. 
This is an important finding that warrants further investigations 
in order to determine the prophylactic and therapeutic effect of 
n-3 FA and CR combination on various inflammatory diseases. 
However, this dietary strategy may not be suitable for peoples 
living in pathogen-rich environments as the reduction of inflam-
matory cytokines will reduce immune system defenses.47-50
Oxidative stress is considered one of the major contributory 
factors of aging and also associated with a number of pathological 312  Oxidative Medicine and Cellular Longevity  Volume 2 Issue 5
conditions. There is evidence that oxidative stress and inflam-
mation are closely related to each other. Where there is oxida-
tive stress, inflammation is likely to occur. Inflammation and 
oxidative stress promote catabolic stimuli, such as, IL-6, IL-1 
and TNFa. Oxidative stress occurs when the balance between 
free radicals and anti-oxidant enzymes favors toward the former. 
That means the more production of ant-oxidant enzymes, the 
less generation of oxidative stress. Both n-3 FA and CR are con-
sidered as anti-oxidative.8 We and others have shown that n-3 FA 
enhance the anti-oxidant defense system of animals and humans 
by increasing the production of anti-oxidant enzymes.40,51,52 The 
beneficial effect of CR in health and diseases is also thought 
to be due mainly to its powerful anti-inflammatory, resistance 
against oxidative stress and its ability to maintain a proper cel-
lular redox status.15 CR is also known to suppress COX-derived 
ROS generation.53 Antioxidant defense system decreases with age 
and CR is shown to prevent these decreases.16 Thus, the effect of 
CR is believed to be due to its powerful anti-oxidative action.15 
Animal studies have shown repeatedly that CR enhances meta-
bolic efficiency, decreases inflammation and increases stress resis-
tances over the lifespan by blunting the age-dependent increase 
of NFκB activation.15,54 In this study, we found a higher level of 
CAT, SOD and GPX in muscle and CAT and SOD in liver of 
Fat-1 mice, as compared to that of WT mice. There was a further 
enhancement of this ant-oxidant enzymes production in Fat-1/
CR mice, as compared to that of WT/CR. These data suggest 
that there is a synergistic effect of endogenous n-3 FA and CR 
on the production of anti-oxidant enzymes, thereby potentially 
enhancing the antioxidant defense system, reducing pathological 
conditions and therefore, may prolong life span.
Both  inflammation  and  oxidative  stress  increase  with  the 
progression of aging (Fig. 7). We previously demonstrated the 
life-prolonging effects of n-3 FA in NZB/W mouse model of 
human SLE, as compared to n-6 FA.14 When n-3 FA was com-
bined with 40% CR, these mice lived significantly longer com-
pared to n-6 FA + CR.55 Recently, life prolonging genes have been 
discovered and named sirtuins (SIRT1-7 in humans), which are 
anti-inflammatory in nature.56 It has been demonstrated that CR 
increases the expression of SIRT-1.38 SIRT1 is likely to directly 
regulate  the  transcriptional  activity  of  NFκB.57  Activation  of 
SIRT-1  induced  by  CR  would  also  explain  the  resistance  to 
inflammation that occurs during CR via the inhibition of NFκB 
signaling. Microarray studies have revealed that the age-related 
pro-inflammatory gene expression profiles can be reprogrammed 
via CR.58 It has been also reported that SIRT-1 attenuates oxi-
dative stress-induced mesangial cell apoptosis via p53 deacety-
lation.59 Sklavounou et al. have reported that SIRT-1 plays an 
important role in preventing differentiation and apoptosis as well 
as increasing cellular resistance to stress.60 It has also been shown 
that overexpression of SIRT-1 enhances neuronal survival by pre-
venting nuclear DNA degradation during oxidative stress.20,61,62 
Activation of SIRT-1 was also shown to be associated with inhibi-
tion of NFκB activation and oxidative stress.63 In this study, we 
found an upregulation of SIRT-1 expression in Fat-1/CR mice, as 
compared to that of WT/CR mice. However, endogenous n-3 FA 
did not modulate the expression of SIRT-1. CR alone did increase 
Figure 5. endogenous n-3 Fa and CR upregulate the level of sirtuin 
(sIRT)-1 expression in liver: after 5 months of dietary intervention, whole 
liver tissue extracts were prepared and performed western blot analysis 
for sIRT-1 protein levels in different experimental groups. The bottom 
lane indicates equal loading of proteins probed for actin antibody. Bars 
represent relative densitometric expression of sIRT1. each bar represents 
the mean ± SEM (n = 4/group). Value with different superscripts are signifi-
cantly different at p < 0.05 by Newman-Keuls’ one way ANOVA. WT/AL, 
wild type ad libitum; WT/CR, wild type calorie restriction; Fat-1/aL, Fat-1 
transgenic ad libitum; Fat-1/CR, Fat-1 transgenic calorie restriction.
Figure 6. endogenous n-3 Fa and CR upregulate the level of peroxisome 
proliferator-activated receptor (ppaR)γ expression in liver: after 5 months 
of dietary intervention, liver nuclear proteins were prepared and analyzed 
for ppaRγ levels using TransaM ppaRγ Activation Assay kit from Active 
Motif. each bar represents the mean ± seM (n = 4/group). Value with dif-
ferent superscripts are significantly different at p < 0.05 by Newman-Keuls’ 
one way aNOVa. WT/aL, wild type ad libitum; WT/CR, wild type calorie 
restriction; Fat-1/aL, Fat-1 transgenic ad libitum; Fat-1/CR, Fat-1 transgenic 
calorie restriction.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  313
mechanisms by which the n-3 FA and CR exert its anti-inflam-
matory and ant-oxidative capacity. Furthermore, by inducing the 
expression of PPARγ, n-3 FA and CR also will improve the glu-
cose, insulin and lipid metabolism, thereby improving the quality 
of life. These are very important new findings, which warrant 
urgent study in order to determine the combined effect of n-3 
FA and CR on the prolongation of life span. Implementation of 
further work to elucidate the cellular mechanisms of n-3 FA and 
CR mediated anti-inflammatory and anti-oxidative activities in 
animals and humans may offer novel dietary approaches for the 
treatment of disorders tied to inflammation and oxidative stress 
as well as for the extension of lifespan.
In conclusion, the present data demonstrate that n-3 FA and 
CR, in combination, may improve the overall pathological con-
ditions,  by  modulating  inflammatory  response  and  oxidative 
stimuli and associated intracellular signaling molecules, with the 
progression of age, thereby improving the quality of aging and 
may extend the lifespan.
Materials and Methods
Animals  and  experimental  diets.  Male  transgenic  Fat-1 
C57BL6 mice were obtained from Dr. Jing Kang at the Harvard 
Medical  School.  They  were  mated  with  wild  type  C57BL6 
female mice to obtain female fat-1 positive C57BL6 mice (Fat-1) 
and fat-1 negative C57BL6 mice (WT) identified by genotyping 
using REDExtract-N-Amp Tissue PCR Kit from Sigma and ana-
lyzing the fatty acid composition of tails by using gas chromatog-
raphy (GC) as described previously.29 Weight-matched mice were 
housed in a laboratory animal care facility in cages (3–4 mice/
cage) and fed semi-purified AIN-93M diets containing 10% corn 
oil (CO) (MP Biomedicals, Irvine, CA). CO is high in linoleic 
acid (18:2n-6) and Fat-1 mice convert n-6 FA to n-3 FA. The 
composition of the semi-purified diet per kilogram of diet was: 
140 g of casein, 424.3 g of corn starch, 145 g of dextronized corn 
SIRT-1 expression, but remarkable augmentation of SIRT-1 was 
observed when combined with endogenous production of n-3 
FA, demonstrating that combination of n-3 FA and CR may 
extend life span even further than CR alone. Thus, combina-
tion of n-3 FA and CR may inhibit inflammation and oxidative 
stress by enhancing the expression of SIRT-1. PPARγ is a master 
regulator of glucose, insulin and lipid metabolism64,65 and n-3 
fatty acid and CR are known to increase PPARγ mRNA and pro-
tein expression.54 PPARγ is also anti-inflammatory by nature.66 
CR is shown to attenuate age-related decreases of PPARs, thus 
boosting the inhibitory effect of PPARs on NFκB activation. 
Further, PPARγ agonists are reported to inhibit inflammatory 
cytokine production and PPARγ is downregulated by inflamma-
tory cytokines.39,67 Moreover, the evidence to date suggests that 
activation of PPARγ should suppress tumor growth and develop-
ment.39 Similar to SIRT-1, very recently, overexpression of PPARγ 
has been shown to be associated with increased resistance against 
oxidative stress.24-27 Moreover, n-3 FA deficiency related hepatic 
steatosis involves reduced protection against endoplasmic reticu-
lum stress due to reduced expression of PPARγ.68 Chung et al. 
reported that in human skeletal muscle cells, the antioxidant 
effect of PPARγ is exclusively mediated by glutathione peroxi-
dase.69 It has also been shown that increased expression of PPARγ 
and SOD1 is associated with decreased accumulation of oxidized 
LDL.70 In this study, we found upregulation of PPARγ expression 
in liver of Fat-1 mice, as compared to that of WT mice. There was 
further augmentation of PPARγ expression in Fat-1/CR mice, as 
compared to WT/CR mice, demonstrating the synergistic effect 
of n-3 FA and CR on the expression of PPARγ. These data sug-
gest that upregulation of PPARγ expression may be one of the 
Table 1. statistical determination of the combined effect of endog-
enously synthesized n-3 fatty acids (Fa) and calorie restriction (CR) on 
different parameters
Parameters Gene Diet Gene X diet
serum n-6/n-3 Fa ratio <0.0001 0.0753 0.4089
Muscle n-6/n-3 Fa ratio <0.0001 0.2847 0.3878
Liver n-6/n-3 Fa ratio <0.0001 0.4705 0.6884
serum TNFa 0.0011 0.0422 0.9157
serum IL-6 <0.0001 0.0346 0.5213
serum IL-1b 0.0006 <0.0001 0.3330
Muscle CaT <0.0001 0.740 0.0482
Muscle sOD 0.5022 0.3324 0.7935
Muscle GpX 0.0022 0.0017 0.7390
Liver CaT 0.0041 0.1114 0.6960
Liver sOD 0.1410 0.2802 0.4146
Liver sIRT-1 0.0671 0.0004 0.0035
Liver ppaRγ <0.0001 0.4350 0.0215
Values represent the p values by Two Way anova using Graph pad 
Prism software. p value <0.05 is considered significant. Gene: Fat-1 gene 
capable of converting n-6 Fa to n-3 Fa. Diet: ad libitum and calorie 
restriction (40% less than ad libitum). TNFa, tumor necrosis factor-a; 
IL-6, interleukin-6; IL-1b, interleukin-1 b; CaT, catalase; sOD, superox-
ide dismutase; GpX, glutathione peroxidase; sIRT-1, sirtuin-1; ppaRγ, 
peroxisome proliferator-activated receptor-γ.
Figure 7. The role of inflammation and oxidative stress in pathophysi-
ological process and the possible action of CR and n-3 Fa.314  Oxidative Medicine and Cellular Longevity  Volume 2 Issue 5
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by the supplier (Pierce Chemical Company, Rockford, IL). SOD 
activity: assay was based on the ability of SOD to inhibit the 
spontaneous oxidation of adrenaline to adrenochrome. Results 
are expressed as units (U) of SOD activity/mg protein. One unit 
of SOD induced approximately 50% inhibition of auto-oxidation 
of adrenaline. CAT activity was measured based on the ability of 
CAT to induce the disappearance of hydrogen peroxide (H2O2), 
which was followed spectrophotometrically.71 One unit (U) was 
defined as the amount of the enzyme required to decompose 1 
mM of H2O2 per min, at 25 1C and pH 7.0. Results are expressed 
as units (U) of CAT activity/mg protein. GPX activity: H2O2 
was used as the substrate. Sodium azide (1 mM) was added to 
the reaction mixture to inhibit remnant CAT activity. One unit 
of GPX was defined as the amount of the enzyme decomposing 1 
mol H2O2 per min, at 25°C and pH 7.0. Results are expressed as 
units (U) of GPX activity/mg protein.
Preparation  of  liver  homogenates.  Cytosolic  and  nuclear 
extracts of liver were prepared using a Nuclear Extract Kit from 
Active Motive (Carlsbad, CA), following manufacturer’s instruc-
tion. Whole liver tissue extracts were prepared using a lysis buffer 
containing 10 mM Tris HCl (pH 7.8), 1% Nonidet P40 (NP40), 
0.15 M Nacl, 1 mM EDTA, 1 mM DTT, 0.1% Triton X, 0.2 
mM AEBSF, 50 mM NaF, 1 mM Na3OVa4 and protease inhibi-
tor cocktail from Roche Diagnostics. 100 mg of liver tissues were 
homogenized  and  briefly  centrifuged  to  separate  debris,  then 
kept on ice for 30 minutes, then centrifuged at 12,000 rpm for 
20 minutes at 4°C and collected supernatant as whole liver tissue 
extract.
Western blot analysis for SIRT-1. 50 μg of whole liver tissue 
extracts were subjected to SDS-PAGE. Proteins were transferred 
to  immunoblot  nitrocellulose  membranes  (BioRad,  Hercules, 
CA) and subjected to western blot analysis to determine the level 
of SIRT-1 in different experimental groups. Polyclonal antibody 
against SIRT-1 and monoclonal antibody against actin obtained 
from Santa Cruz Biotechnology Inc., were used. Western blot 
was performed as described earlier.72,73
Analysis of PPARγ in liver. Nuclear extracts of liver samples 
were  used  to  determine  the  level  of  PPARγ  using  TransAM 
PPARγ Activation Assay Kit (Cat # 40196) from Active Motif, 
following manufacturer’s instruction.
Statistical analysis. Data are expressed as means ± SEM. To 
test the significance either student’s t-test or Newman-Keuls’ one 
way ANOVA was used. A p value ≤0.05 was considered statisti-
cally significant. The analyses were performed using Graphpad 
prism for Windows (La Jolla, CA, USA).
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starch, 90 g of sucrose, 50 g of fiber, 35 g of AIN-93 mineral 
mix, 10 g of AIN-93 vitamin mix, 1.8 g of l-cystine and 2.5 g 
of choline bitartrate. Diets were prepared weekly and stored in 
aliquots at -20°C. Fresh diet was provided daily, and leftover food 
was removed to prevent rancidity. At 6 months of age, weight-
matched mice were divided into ad libitum (AL) and calorie-
restricted (CR, food provided gradually lowered to 40% less than 
AL) groups resulting in 4 dietary groups—WT/AL, Fat-1/AL, 
WT/CR and Fat-1/CR. Mice (n = 7–8/group) were maintained 
on the experimental diets for 5 mo until sacrifice. At the end of 
experimental diet, body weights measured for WT/AL, WT/CR, 
Fat-1/AL and Fat-1/CR groups were 36.54 ± 2.55 g, 23.70 ± 0.66 
g, 33.90 ± 3.30 g and 25.74 ± 1.30 g respectively. The National 
Institutes of Health guidelines provided in “The Guide for the 
Care and Use of Laboratory Animals” were strictly followed, and 
all studies were approved by the Institutional Laboratory Animal 
Care  and  Use  Committee  of  the  University  of  Texas  Health 
Science Center at San Antonio.
Collection of blood serum. At the termination of the study, 
blood was collected and serum was obtained by centrifugation at 
300 g for 15 min at 4°C.
Serum  cytokine  measurement.  Serum  cytokine  levels  for 
TNFa,  IL-6  and  IL-1b  were  measured  by  standard  enzyme-
linked  immunosorbent  assay  (ELISA)  techniques  using  com-
mercially  available  BD  OptEIA  ELISA  kits  for  TNFa,  IL-6 
and IL-1b (BD Biosciences, San Diego, CA), as described pre-
viously.51 Each well of flat-bottom 96-well microtiter plates was 
coated overnight with 100 μl of purified anti-TNFa, anti-IL-6 
or anti-IL-1b antibodies (4 μg/ml in binding solution) at 4°C. 
The plates were rinsed four times with washing buffer, and then 
samples were added, followed by incubation for 2 h at room tem-
perature. The plates were washed four times with washing buffer, 
followed by the addition of biotinylated anticytokine antibodies. 
The plates were incubated in room temperature for 1 h and then 
washed four times with washing buffer. Streptavidin–alkaline 
phosphatase conjugate was added, and the plates were incubated 
for 30 min at room temperature. The plates were again washed 
four times with washing buffer, and chromogen substrate was 
added. The plates were then incubated at room temperature to 
achieve the desired maximum absorbance and were read at 410 
nm in an ELISA reader (Dynex Technologies, UK).
Measurement  of  anti-oxidant  enzymes  activity  in  muscle 
and liver. The muscles (gastrocnemius and quadriceps) and liver 
tissues obtained from different experimental groups were homog-
enized in 2 ml tris-HCl buffer (pH 7.4) and sonicated for 16 s. 
Thereafter, the homogenates were centrifuged (10,000 g for 2 
min) and the supernatant were used for the estimation of SOD, 
CAT and GPX, as described previously.40,51 The protein content 
of spleen supernatants was determined by the microplate proce-
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